價格 | 詢價 | ||
包裝 | 100ug | 500ug | 1000ug |
最小起訂量 | 100ug |
發(fā)貨地 | 北京 |
更新日期 | 2024-12-16 |
中文名稱:DR6蛋白 | 英文名稱:TNFRSF21 |
品牌: 百普賽斯 | 產(chǎn)地: 北京 |
保存條件: -20°C to -70°C | 純度規(guī)格: 99.9% |
產(chǎn)品類別: 重組蛋白 | |
貨號: TNFRSF21 | 用途范圍: 藥物開發(fā)等 |
規(guī)格: 100ug | 是否進口: 否 |
英文名稱:Tumor necrosis factor receptor superfamily member 21
中文名稱:腫瘤壞死因子受體超家族成員21
靶點別稱:TNFRSF21,DR6,CD358,BM-018
物種:Human
標(biāo)簽:Fc Tag
屬性:Protein
標(biāo)記:Unconjugated
表達區(qū)間及表達系統(tǒng)(Source)
Human DR6, Fc Tag (TN1-H5252) is expressed from human 293 cells (HEK293). It contains AA Gln 42 - Leu 350 (Accession # AAH17730).
Predicted N-terminus: Gln 42
蛋白結(jié)構(gòu)(Molecular Characterization)
This protein carries a human IgG1 Fc tag at the C-terminus.
The protein has a calculated MW of 60.2 kDa. The protein migrates as 80-95kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.
內(nèi)毒素(Endotoxin)
Less than 1.0 EU per μg by the LAL method.
純度(Purity)
>90% as determined by SDS-PAGE.
制劑(Formulation)
Lyophilized from 0.22 μm filtered solution in 50 mM Tris, 100 mM Glycine, 150 mM NaCl, pH7.5. Normally trehalose is added as protectant before lyophilization.
Contact us for customized product form or formulation.
重構(gòu)方法(Reconstitution)
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
存儲(Storage)
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.
背景(Background)
腫瘤壞死因子受體超家族成員21(TNFRSF21)也稱為死亡受體6(DR6),是TNF受體超家族的成員。TNFRSF21包含一個死亡結(jié)構(gòu)域和四個TNFR-Cys重復(fù)序列。TNFRSF21/DR6已被證明可以激活NF-κB和MAPK8/JNK,并誘導(dǎo)細(xì)胞凋亡。通過其死亡結(jié)構(gòu)域,該受體與TRADD蛋白相互作用,TRADD蛋白被認(rèn)為是介導(dǎo)TNF受體信號轉(zhuǎn)導(dǎo)的接頭。
成立日期 | 2010-07-22 (15年) | 注冊資本 | 8000萬人民幣 |
員工人數(shù) | 500人以上 | 年營業(yè)額 | ¥ 1億以上 |
主營行業(yè) | 醫(yī)藥中間體,原料藥,激素類,氨基糖苷類,中樞神經(jīng)系統(tǒng)用藥 | 經(jīng)營模式 | 工廠,試劑 |
產(chǎn)品名稱 | 價格 | 公司名稱 | 報價日期 | |
---|---|---|---|---|
¥1950 |
VIP3年
|
上海滬震實業(yè)有限公司
|
2025-01-17 | |
¥2460 |
VIP6年
|
上海澤葉生物科技有限公司
|
2025-01-20 | |
¥2300 |
VIP4年
|
上海博爾森生物科技有限公司
|
2025-01-17 |